Everything below concerns mass spectrometry. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-08-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual inspection of dry material |
| Solubility | Soluble in water | Polar aqueous solvent class |
| Typical storage | Minus 20 degrees Celsius, desiccated, dark | Applies to the lyophilized form |
| Purity assessment | Reversed-phase HPLC | Ultraviolet detection, area percent |
| Identity confirmation | Mass spectrometry | Measured mass compared with theoretical value |
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Subclass Nautiloidea: Fundamental ectocochliate cephalopods that provided the source for the Ammonoidea and Coleoidea. Order † Plectronocerida: the ancestral cephalopods from the Cambrian Period Order † Ellesmerocerida (500 to 470 Ma) Order † Endocerida (485 to 430 Ma) Order † Actinocerida (480 to 312 Ma) Order † Discosorida (482 to 392 Ma) Order † Pseudorthocerida (432 to 272 Ma) Order † Tarphycerida (485 to 386 Ma) Order † Oncocerida (478.5 to 324 Ma) Order Nautilida (extant; 410.5 Ma to present) Order † Orthocerida (482.5 to 211.5 Ma) Order † Ascocerida (478 to 412 Ma) Order † Bactritida (418.1 to 260.5 Ma) Subclass † Ammonoidea: ammonites (479 to 66 Ma) Order † Goniatitida (388.5 to 252 Ma) Order † Ceratitida (254 to 200 Ma) Order † Ammonitida (215 to 66 Ma) Subclass Coleoidea (410.0 Ma-Rec) Cohort † Belemnoidea: Belemnites and kin Genus † Jeletzkya Order † Aulacocerida (265 to 183 Ma) Order † Phragmoteuthida (189.6 to 183 Ma) Order † Hematitida (339.4 to 318.1 Ma) Order † Belemnitida (339.4 to 66 Ma) Genus † Belemnoteuthis (189.6 to 183 Ma) Cohort Neocoleoidea Superorder Decapodiformes (also known as Decabrachia or Decembranchiata) Order Spirulida: ram's horn squid Order Sepiida: cuttlefish Order Sepiolida: pygmy, bobtail and bottletail squid Order Idiosepida Order Oegopsida: neritic squid Order Myopsida: coastal squid Order Bathyteuthida Superorder Octopodiformes (also known as Vampyropoda) Family † Trachyteuthididae Order Vampyromorphida: vampire squid Order Octopoda: octopus Superorder † Palaeoteuthomorpha Order † Boletzkyida Other classifications differ, primarily in how the various decapod orders are related, and whether they should be orders or families.
Nevertheless, the successful synthesis of superheavy elements up to Z = 118 (oganesson) with up to 177 neutrons demonstrates a slight stabilizing effect around elements 110 to 114 that may continue in heavier isotopes, consistent with the existence of the island of stability.
Investigators nationwide may compete for pilot funding and access to the Center's specialized cores, fostering new collaborations and expanding the national aging research community. These activities complement the Barshop Institute's NIH-funded Biology of Aging Training Program (T32), creating a rich educational environment for predoctoral students, postdoctoral fellows, and junior faculty.
Sources: en.wikipedia.org
The primary function of the corticotropic cells is to produce the prohormone POMC in response to the release of CRH from the hypothalamus. POMC is cleaved into several peptide hormones via enzyme activity. In addition to synthesis in the corticotropes, POMC is also synthesized in melanotroph cells, the arcuate nucleus of the hypothalamus, and melanocytes. POMC undergoes differential cleavage into various peptide hormones depending on the cell it is synthesized in; it also varies based on species. POMC in the corticotropes of humans is proteolytically cleaved by proprotein convertases into ACTH and β-lipotropin. In rats, however, the ACTH is further cleaved into α-MSH and CLIP in the corticotrope. These peptide hormones are stored within vesicles in the corticotropic cells and are released in response to CRH stimulation from the hypothalamus. These vesicles then leave the anterior pituitary and travel throughout the body via the bloodstream to reach their target tissues.
== Diagnosis == Diagnosis of Bruck syndrome must distinguish the association of contractures and skeletal fragility. Ultrasound is used for prenatal diagnosis. The diagnosis of a neonate bears resemblance to arthrogryposis multiplex congenital, and later in childhood to osteogenesis imperfecta.
The State Council said inspectors would target edible oil trade fairs and wholesale markets and called for inspections of oil being used at restaurants, school cafeterias, work canteens and kitchens at construction sites. The State Council also stated that businesses that use recycled oil would be forced to close temporarily or lose their business license while peddlers who sell the oil could be criminally prosecuted. In October 2013, a man from eastern China's Jiangsu Province was sentenced to life imprisonment for profiting heavily from making and selling gutter oil. In January 2014, Zhu Chuanfeng was sentenced to death with a two-year reprieve, and his brothers Zhu Chuanqing and Zhu Chuanbo were sentenced to life in prison for selling gutter oil.
antioncogene A gene which helps to regulate cell growth and suppress tumors when functioning correctly, such that its absence or malfunction can result in uncontrolled cell growth and possibly cancer. Compare oncogene.
Sources: en.wikipedia.org
Immediately after the split, William Reid went solo as Lazycame—having already released a solo EP in April 1998—and Jim Reid founded Freeheat along with Lurie and ex-Gun Club bassist Romi Mori and Earl Brutus drummer Nick Sanderson, although neither act received much attention or found any success. In October 2005, it was announced that the Reids were reunited; Jim Reid's track "Song for a Secret" a duet with his wife Julie Barber, was released as a single, paired up with Sister Vanilla's "Can't Stop The Rock", which was written and produced by William and the brothers' younger sibling, Linda. The single was released by Transistor Records on 17 October. Jim promoted his side of the single with a very rare solo gig at London's Sonic Cathedral club on John Peel Day, Thursday 13 October 2005. He finished the appearance with a performance of the early Mary Chain classic "Never Understand". Jim also performed new material at low-key gigs with a new band comprising Phil King on guitar, Loz Colbert (Ride) on drums and bassist Mark Crozer (International Jetsetters). In 2006 five albums were reissued through Rhino Records: Psychocandy, Darklands, Automatic, Honey's Dead and Stoned & Dethroned on 11 July 2006. Each album was released with a DVD containing three promo videos from that particular album.
=== No development reported === Adapalene/minocycline (FCD-105) – combination of adapalene (retinoid) and minocycline (tetracycline antibiotic) Auriclosene (AgaDerm; AgaNase; AL-46383A; CD-07223; DCDMT; NVC-422) – aganocide compound and antimicrobial Bermekimab (CA-18C3; CV-18C3; Hutruo; JNJ-77474462; MAB-p1; RA-18C3; T2-18C3; Xilonix) – monoclonal antibody against interleukin-1α BOS-356 (GSK-3008356) – diacylglycerol O-acyltransferase inhibitor Brilacidin (PMX-30063) – host defense protein (HDP) mimetic antibiotic Carbamide peroxide topical (E-0301) – disinfectant and bleaching agent CJM-112 – IL17A and IL17F inhibitor Clindamycin/tretinoin – combination of clindamycin (lincosamide antibiotic) and tretinoin (retinoid) Clindamycin/tretinoin – combination of clindamycin (lincosamide antibiotic) and tretinoin (retinoid) DMT-200 (DMT-210; DMT-220; SIG-990) – isoprenylcysteine analogue and various actions Estradiol valerate/dienogest (Climodien; Climodiène; Klimodien; Lafamme) – combination of estradiol valerate (estrogen) and dienogest (progestogen) Ethinylestradiol/chlormadinone acetate (Balianca; Belara; GRT4248) – combination of ethinylestradiol (estrogen) and chlormadinone acetate (progestogen) and a combined oral contraceptive Ethinylestradiol/drospirenone (Petibelle; SH-470; Yasmin; ZK-30595) – combination of ethinylestradiol (estrogen) and drospirenone (progestogen) GSK-1940029 – stearoyl-CoA desaturase inhibitor GT-20029 (AR-PROTAC) – androgen receptor degradation enhancer IP10-C8 – CD13 antigen inhibitor and dipeptidyl peptidase 4 (DPP4) inhibitor Minocycline extended release (Emrosi; Ximino) – tetracycline antibiotic Minocycline topical (HY01) – tetracycline antibiotic MTC-896 – melanocortin receptor antagonist Nitric oxide (Enovid; FabiSpray; NORS-0791; NORS-1002; NORS-2791; NORS-4002; NORS-6491; NORS) – nitric oxide donor ORG-101 (acne vulgaris vaccine; ORI-001; ORI-A-ce001) – immunostimulant, vaccine Radezolid (RX-01667; Rx-01_667; RX-103; RX-1741) – oxazolidone antibiotic Research programme: antimicrobial therapies - NovaBiotics – cell membrane permeability enhancers Research programme: synthetic cannabinoid therapeutics - Claritas Pharmaceuticals – cannabinoids (cannabinoid receptor modulators) Research programme: therapeutic antibody fragments - Kuur Therapeutics – various actions Silver dihydrogen citrate (SDC; Axenohl) – antiseptic/antibacterial Tazarotene topical (DFD-03) – retinoid X receptor agonist
As with any sterilisation method, a very small proportion of germs may survive the process, and cause a fraction of the irradiated products to spoil anyway. The risk comes from the false sense of security. As mentioned above, the treatment only preserves the freshness of the product at the moment it reaches the factory. If it has already lost some of its qualities, this will not be restored, and may even be hidden by the packaging. While the purpose of the irradiation is to degrade the DNA/RNA of contaminating germs, a small proportion of the nutrient load is also degraded in the process. In particular, vitamins, whole proteins and aromatic molecules. The irradiation creates highly reactive radicals, which would cause problems if the food is consumed immediately after being irradiated.
Sources: en.wikipedia.org
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.
Mass spectrometry establishes the molecular mass, and reversed-phase chromatography reports purity. A certificate of analysis typically combines both results.
Solutions degrade faster than the dry powder, particularly at room temperature. Portioning into single-use aliquots and freezing reduces losses from repeated thawing.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.